Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849556) titled 'AnteAGE Biosomes With Radiofrequency Microneedling for Facial Skin Rejuvenation' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Cellese Inc.
Condition:
Skin Aging
Facial Rhytides
Skin Tone
Intervention:
Other: AnteAGE Biosome Treatment Solution
Device: Radiofrequency Microneedling
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: December 3, 2024
Target Sample Size: 30
Countries of Recruitment:
United States
To know ...